dpp 4 inhibitors vs glp 1 GLP-1 Receptor Agonists Have better Outcomes Than DPP4 in T2D patients & CKD Prescribing pearls: A guide to

Look for simple formulations that minimize potential irritants

After the first portion is added, pause

Purpose-built for physicians Dip in bariatric surgeries shows emerging medical options first approach to weight loss Key takeaways: GLP-1 receptor agonist prescriptions for obesity treatment grew by 132.6% from 2022 to 2023

For many patients, this translates to nausea, particularly in the early weeks of treatment or when doses are increased

Florida Surgery & Weight Loss Center 1911 Harrison Street Hollywood, FL 33020 (954) 551-3508 Compounded tirzepatide and semaglutide are not FDA-approved and may be prescribed when medically appropriate for eligible patients

Regular monitoring helps prevent complications and allows for necessary adjustments to enhance effectiveness